Meghmani Finechem - Epigral Share Price

Meghmani Finechem - Epigral Share Price

  • 1,113.106.90 (0.63%)
  • Closed
  • As On: 29 Jun, 2026, 03:51 PM IST
Loading...
Open1,097.90
High1,140.00
Low1,093.10
Prev Close1,106.20
Volume17,013
VWAP(₹)1,104.59

Key Metrics

PE Ratio(x)14.47
EPS - TTM(₹)76.95
MCap(₹ Cr.)4,802.06
MCap Rank27
PB Ratio(x)2.15
Div Yield(%)0.45
Face Value(₹)10.00
52W High(₹)2,114.00
52W Low(₹)807.00
MCap/Sales1.38
Beta(1 Month)-
BV/Share(₹)514.92

Meghmani Finechem share price insights

  • Employee & Interest Expense

    Company has spent 2.85% of its operating revenues towards interest expenses and 5.13% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Meghmani Finechem Share Price Update

    Epigral Ltd. share price moved up by 0.63% from its previous close of Rs 1,106.20. Epigral Ltd. stock last traded price is 1,113.10

    Share PriceValue
    Today/Current/Last1,113.10
    Previous Day1,106.20

Found Insights useful?

Meghmani Finechem Share Price Returns

1 Day0.63%
1 Month-4.12%
3 Months32.67%
1 Year-38.17%
3 Years-0.13%
5 YearsN.A.

Meghmani Finechem Share Recommendations

Mean recosCurrent
STRONG BUY

1 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy1111
Buy----
Hold----
Sell----
Strong Sell----
# Analysts1111

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income735.59602.68589.10614.79631.03
    Total Income Growth (%)22.052.31-4.18-2.57-2.78
    Total Expenses609.27537.13497.31484.69488.20
    Total Expenses Growth (%)13.438.012.60-0.72-1.50
    EBIT126.3265.5591.79130.10142.83
    EBIT Growth (%)92.71-28.59-29.45-8.91-6.93
    Profit after Tax (PAT)80.9539.1151.22160.6986.89
    PAT Growth (%)106.98-23.64-68.1284.93-16.15
    EBIT Margin (%)17.1710.8815.5821.1622.63
    Net Profit Margin (%)11.006.498.6926.1413.77
    Basic EPS (₹)18.769.0711.8737.2520.14
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income735.59602.68589.10614.79631.03
    Total Income Growth (%)22.052.31-4.18-2.57-2.78
    Total Expenses609.27537.13497.31484.69488.20
    Total Expenses Growth (%)13.438.012.60-0.72-1.50
    EBIT126.3265.5591.79130.10142.83
    EBIT Growth (%)92.71-28.59-29.45-8.91-6.93
    Profit after Tax (PAT)81.9339.1551.52160.4186.62
    PAT Growth (%)109.27-24.01-67.8885.19-16.34
    EBIT Margin (%)17.1710.8815.5821.1622.63
    Net Profit Margin (%)11.146.508.7526.0913.73
    Basic EPS (₹)18.999.0811.9437.1820.08
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue2,542.162,565.341,935.762,196.381,555.05
    Total Revenue Growth (%)-0.9032.52-11.8741.2487.18
    Total Expenses2,200.362,025.241,645.031,673.911,171.63
    Total Expenses Growth (%)8.6523.11-1.7242.8774.89
    Profit after Tax (PAT)331.97357.69195.87353.29252.79
    PAT Growth (%)-7.1982.62-44.5639.76150.68
    Operating Profit Margin (%)16.3723.2618.8726.8627.57
    Net Profit Margin (%)13.1314.0210.1516.1416.29
    Basic EPS (₹)76.9584.6847.1485.0360.84
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue2,542.162,565.341,935.712,196.381,555.05
    Total Revenue Growth (%)-0.9032.53-11.8741.2487.18
    Total Expenses2,200.362,025.241,645.031,673.861,171.63
    Total Expenses Growth (%)8.6523.11-1.7242.8774.89
    Profit after Tax (PAT)333.01356.70195.79353.36252.79
    PAT Growth (%)-6.6482.19-44.5939.78150.68
    Operating Profit Margin (%)16.3723.2618.8726.8727.57
    Net Profit Margin (%)13.1713.9810.1416.1416.29
    Basic EPS (₹)77.1984.4547.1285.0460.84

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent 2.85% of its operating revenues towards interest expenses and 5.13% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets3,505.303,152.442,794.342,432.242,123.67
    Total Assets Growth (%)11.1912.8214.8914.5346.59
    Total Liabilities1,283.871,247.911,485.241,253.141,397.70
    Total Liabilities Growth (%)2.88-15.9818.52-10.3482.81
    Total Equity2,221.431,904.531,254.101,069.10725.97
    Total Equity Growth (%)16.6451.8617.3047.2753.41
    Current Ratio (x)1.161.570.640.650.84
    Total Debt to Equity (x)0.250.310.720.721.36
    Contingent Liabilities315.34279.21110.44293.41192.72
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets3,505.343,151.442,794.332,432.252,123.67
    Total Assets Growth (%)11.2312.7814.8914.5346.59
    Total Liabilities1,283.871,247.911,485.241,253.091,397.70
    Total Liabilities Growth (%)2.88-15.9818.53-10.3582.80
    Total Equity2,221.471,903.531,254.091,069.17725.97
    Total Equity Growth (%)16.7051.7917.3047.2753.41
    Current Ratio (x)1.161.570.640.650.84
    Total Debt to Equity (x)0.250.310.720.721.36
    Contingent Liabilities315.34279.21222.10293.41242.60

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities435.53440.56397.64626.16283.82
    Net Cash used in Investing Activities-354.67-261.56-401.10-437.22-454.63
    Net Cash flow from Financing Activities-94.48-163.54-7.60-199.79195.22
    Net Cash Flow-13.6215.46-11.06-10.8524.41
    Closing Cash & Cash Equivalent5.0218.643.1814.2425.09
    Closing Cash & Cash Equivalent Growth (%)-73.07485.61-77.65-43.233,589.03
    Total Debt/ CFO (x)1.291.332.281.223.49
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities435.53440.56397.69626.16283.82
    Net Cash used in Investing Activities-354.67-261.56-401.10-437.22-454.68
    Net Cash flow from Financing Activities-94.48-163.54-7.60-199.79195.22
    Net Cash Flow-13.6215.46-11.01-10.8524.36
    Closing Cash & Cash Equivalent5.0218.643.1814.1925.04
    Closing Cash & Cash Equivalent Growth (%)-73.07485.61-77.57-43.323,581.68
    Total Debt/ CFO (x)1.291.332.281.223.49

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Increase in Cash from Investing

      Company has used Rs 354.67 cr for investing activities which is an YoY increase of 35.6%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)14.9418.7815.6133.0434.82
    Return on Capital Employed (%)14.8022.3018.0732.9426.87
    Return on Assets (%)9.4711.347.0014.5211.90
    Interest Coverage Ratio (x)8.0913.636.6410.6411.60
    Asset Turnover Ratio (x)0.760.860.740.960.87
    Price to Earnings (x)10.5322.9423.2611.1016.03
    Price to Book (x)1.574.303.633.675.57
    EV/EBITDA (x)6.9612.0611.306.869.76
    EBITDA Margin (%)23.0328.4625.2831.8433.11
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)14.9918.7315.6133.0434.82
    Return on Capital Employed (%)14.8022.3118.0732.9426.87
    Return on Assets (%)9.5011.317.0014.5211.90
    Interest Coverage Ratio (x)8.0913.636.6410.6411.60
    Asset Turnover Ratio (x)0.760.860.740.960.87
    Price to Earnings (x)10.4922.9923.3111.1016.03
    Price to Book (x)1.574.303.633.675.57
    EV/EBITDA (x)6.9612.0611.306.869.76
    EBITDA Margin (%)23.0328.4625.2831.8433.11

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters2,96,95,53068.83 %0.00
    Pledge00.00 %0.00
    FII6,65,2811.54 %-0.82
    DII21,15,1324.90 %-0.22
    MF21,14,6054.90 %-0.18
    Others1,06,65,39524.72 %1.04
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters68.8368.8368.8368.83
    Pledge0.000.000.000.00
    FII1.542.362.713.05
    DII4.905.134.934.78
    Mutual Funds4.905.094.744.59
    Others24.7223.6823.5323.34

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Corporate Actions

  • General Meeting

    -

    May 14, 2026

    Final

    50%

    May 04, 2026

    Board Meeting

    Audited Results & Final Dividend

    Apr 27, 2026

  • Announced onMeeting on
    Apr 27, 2026May 02, 2026
    Audited Results & Final Dividend
    Jan 20, 2026Jan 30, 2026
    Quarterly Results
    Nov 04, 2025Nov 10, 2025
    Quarterly Results
    Jul 29, 2025Aug 02, 2025
    Quarterly Results & Fund Raising
    Apr 23, 2025May 05, 2025
    Audited Results & Final Dividend
  • Announced onEx-DateDividend%
    May 04, 2026Jun 01, 202650%
    May 05, 2025Jun 20, 202535%
    Jan 27, 2025Feb 07, 202525%
    Apr 22, 2024Jul 02, 202450%
    Apr 25, 2023Jun 20, 202325%
  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    May 14, 2026Jun 08, 2026
    -
    Apr 17, 2026May 21, 2026
    -
    Jun 05, 2025Jun 28, 2025
    -
    Apr 15, 2025May 19, 2025
    -
    Aug 19, 2024Sep 18, 2024
    -

About Meghmani Finechem

Epigral Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 4,802.06 Crore) operating in Chemicals sector.

Show More

Key Indices Listed On

BSE SmallCap, BSE Commodities, BSE AllCap, BSE NEXT 500, BSE MidSmallCap

Address

�Epigral Tower�,Behind Safal Profitaire,Corporate Road,Ahmedabad, Gujarat - 380015

Executive Leadership

MP

Maulik Patel

Chairman & Managing Director
KS

Kaushal Soparkar

Executive Director
AP

Ankit Patel

Non Exe.Non Ind.Director
DP

Darshan Patel

Non Exe.Non Ind.Director
Show More

Auditors

S R B C & Co. LLP

FAQs about Meghmani Finechem share

  • 1. What's Meghmani Finechem share price today and what are Meghmani Finechem share returns ?
    Meghmani Finechem share price is Rs 1,113.10 as on 29 Jun, 2026, 03:51 PM IST. Meghmani Finechem share price is up by 0.63% based on previous share price of Rs. 1129.6.
  • 2. What are the returns for Meghmani Finechem share?
    Return Performance of Meghmani Finechem Shares:
    • 1 Week: Meghmani Finechem share price moved down by 1.77%
  • 3. What is Meghmani Finechem's 52 week high / low?
    In last 52 weeks Meghmani Finechem share had a high price of Rs 2,114.00 and low price of Rs 807.00
  • 4. What is the PE & PB ratio of Meghmani Finechem?
    The PE ratio of Meghmani Finechem stands at 14.38, while the PB ratio is 2.15.
  • 5. What's the market capitalization of Meghmani Finechem?
    Meghmani Finechem share has a market capitalization of Rs 4,802.06 Cr. Within Chemicals sector, it's market cap rank is 27.

Top Gainers

As on 04:10 PM | 29 Jun 2026
Zydus Wellness
569.45
51.36 (9.92%)
Schneider
1,453.60
118.30 (8.86%)
Ather Energy
1,083.75
85.00 (8.52%)
Ami Organics
3,568.20
268.20 (8.13%)
Honasa Consumer
446.45
28.75 (6.89%)

Top Losers

As on 04:10 PM | 29 Jun 2026
Persistent System
4,298.50
-543.00 (-11.22%)
Netweb Technologies
4,454.80
-489.00 (-9.90%)
Astral Poly Tech
1,368.00
-118.91 (-8.00%)
Asahi Ind Glass
838.80
-60.11 (-6.69%)
Supreme Ind.
3,194.00
-227.91 (-6.67%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.